Asset Dedication, LLC Amgen Inc Transaction History

Asset Dedication, LLC

  • $1.46 Billion
  • Q3 2024

A detailed history of Asset Dedication, LLC transactions in Amgen Inc stock. As of the latest transaction made, Asset Dedication, LLC holds 16,953 shares of AMGN stock, worth $4.75 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
16,953
Previous 19,091 11.2%
Holding current value
$4.75 Million
Previous $5.96 Million 8.42%
% of portfolio
0.37%
Previous 0.42%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024
SELL
$309.38 - $337.38 $661,454 - $721,318
-2,138 Reduced 11.2%
16,953 $5.46 Million
Q2 2024

Aug 06, 2024
BUY
$262.75 - $319.31 $434,588 - $528,138
1,654 Added 9.49%
19,091 $5.96 Million
Q1 2024

Apr 16, 2024
SELL
$268.87 - $324.56 $47,052 - $56,798
-175 Reduced 0.99%
17,437 $4.97 Million
Q4 2023

Feb 08, 2024
BUY
$255.7 - $288.46 $383,294 - $432,401
1,499 Added 9.3%
17,612 $5.07 Million
Q3 2023

Nov 13, 2023
BUY
$218.65 - $271.46 $471,409 - $585,267
2,156 Added 15.45%
16,113 $4.33 Million
Q2 2023

Aug 21, 2023
BUY
$214.27 - $253.37 $110,991 - $131,245
518 Added 3.85%
13,957 $3.12 Million
Q1 2023

Apr 21, 2023
BUY
$225.79 - $275.2 $8,805 - $10,732
39 Added 0.29%
13,439 $3.24 Million
Q4 2022

Jan 19, 2023
BUY
$229.03 - $291.01 $256,971 - $326,513
1,122 Added 9.14%
13,400 $3.54 Million
Q3 2022

Oct 27, 2022
BUY
$224.46 - $253.15 $77,887 - $87,843
347 Added 2.91%
12,278 $2.75 Million
Q2 2022

Jul 19, 2022
BUY
$230.71 - $256.74 $290,463 - $323,235
1,259 Added 11.8%
11,931 $2.88 Million
Q1 2022

Apr 21, 2022
BUY
$219.27 - $242.57 $325,835 - $360,459
1,486 Added 16.18%
10,672 $2.56 Million
Q4 2021

Jan 21, 2022
BUY
$198.88 - $227.6 $191,521 - $219,178
963 Added 11.71%
9,186 $2.04 Million
Q3 2021

Oct 18, 2021
SELL
$212.27 - $248.7 $224,157 - $262,627
-1,056 Reduced 11.38%
8,223 $1.74 Million
Q2 2021

Jul 21, 2021
BUY
$233.58 - $259.14 $582,782 - $646,554
2,495 Added 36.78%
9,279 $2.25 Million
Q1 2021

May 03, 2021
SELL
$221.91 - $258.6 $251,424 - $292,993
-1,133 Reduced 14.31%
6,784 $1.66 Million
Q4 2020

Jan 28, 2021
BUY
$216.38 - $257.67 $234,772 - $279,571
1,085 Added 15.88%
7,917 $1.82 Million
Q3 2020

Oct 20, 2020
BUY
$234.65 - $260.95 $126,711 - $140,913
540 Added 8.58%
6,832 $1.75 Million
Q2 2020

Aug 24, 2020
BUY
$197.81 - $242.74 $45,694 - $56,072
231 Added 3.81%
6,292 $1.48 Million
Q1 2020

May 05, 2020
SELL
$182.24 - $241.7 $31,163 - $41,330
-171 Reduced 2.74%
6,061 $1.23 Million
Q4 2019

Jan 31, 2020
BUY
$189.21 - $243.2 $129,230 - $166,105
683 Added 12.31%
6,232 $1.5 Million
Q3 2019

Oct 17, 2019
BUY
$174.11 - $208.62 $6,267 - $7,510
36 Added 0.65%
5,549 $1.07 Million
Q2 2019

Jul 23, 2019
BUY
$166.7 - $195.41 $44,675 - $52,369
268 Added 5.11%
5,513 $1.02 Million
Q1 2019

Apr 19, 2019
SELL
$180.87 - $203.88 $2,170 - $2,446
-12 Reduced 0.23%
5,245 $991,000
Q4 2018

Feb 12, 2019
SELL
$178.4 - $208.25 $74,571 - $87,048
-418 Reduced 7.37%
5,257 $1.02 Million
Q3 2018

Oct 26, 2018
BUY
$185.29 - $208.89 $74,116 - $83,556
400 Added 7.58%
5,675 $1.18 Million
Q2 2018

Aug 13, 2018
BUY
$166.05 - $186.51 $3,985 - $4,476
24 Added 0.46%
5,275 $971,000
Q1 2018

Apr 19, 2018
BUY
$169.43 - $198.0 $228,730 - $267,300
1,350 Added 34.61%
5,251 $900,000
Q4 2017

Jan 17, 2018
BUY
$168.79 - $188.59 $203,054 - $226,873
1,203 Added 44.59%
3,901 $679,000
Q3 2017

Oct 18, 2017
BUY
$167.29 - $191.0 $451,348 - $515,318
2,698
2,698 $503,000

Others Institutions Holding AMGN

# of Institutions
3,123
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Asset Dedication, LLC Portfolio

Follow Asset Dedication, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Dedication, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Dedication, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email